Vitality Watch

Dossier pubmed review 10-aug-2026
Narrative review or expert overview without new data

Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.

Key claim: Knee osteoarthritis is a phenotype of joint aging best preserved with weight reduction, exercise, and education as core healthspan interventions, while pharmacologic and injectable therapies mainly modulate symptoms and genicular artery embolization remains incompletely validated against sham.

Abstract

Knee osteoarthritis (KOA) is a leading cause of late-life pain, mobility loss, and disability, and is increasingly recognized as a phenotype-dependent manifestation of joint aging rather than a purely mechanical disorder. Cellular senescence, inflammaging, mitochondrial dysfunction, synovial inflammation, vascular remodeling, and impaired repair capacity converge to shape KOA symptoms and progression. This narrative review synthesizes evidence on conservative and minimally invasive KOA therapies within a geroscience-guided, phenotype-informed framework. A structured search of PubMed/MEDLINE and Embase from January 2010 to May 2026 identified randomized trials, meta-analyses, guidelines, position statements, and high-quality observational studies evaluating lifestyle interventions, pharmacologic and nutritional strategies, intra-articular therapies, genicular nerve ablation, and genicular artery embolization (GAE). Weight reduction, exercise, and education remain core joint healthspan interventions, with consistent evidence for pain reduction, functional benefit, and favorable systemic effects on inflammation and metabolism. Pharmacologic analgesia, intra-articular corticosteroids, and hyaluronic acid are best interpreted as symptom modulators, while platelet-rich plasma, autologous conditioned serum, and mesenchymal stromal/stem cell-based approaches remain limited by heterogeneity and insufficient long-term structural data. Genicular nerve ablation may support functional longevity through pain control without structural modification. GAE is biologically plausible for synovitis/hypervascularity-dominant KOA, but sham-controlled evidence remains inconsistent. Future trials should distinguish symptomatic relief from true modification of joint aging biology.

Why this matters

This review reframes knee osteoarthritis as a phenotype of joint aging, which lets the Trends & Protocols area situate popular procedural offerings (GAE, nerve ablation, regenerative injectables) inside a hierarchy where weight loss, exercise, and education carry the healthspan weight and procedures mostly modulate symptoms. It is a consolidation, not new primary data, so it strengthens the framing on these pages without upgrading the underlying evidence tier for any single procedure — notably GAE, which the authors flag as still not convincingly separated from sham.

Source

Link

Briefing card

Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.
Stage: review · pubmed · 10-aug-2026

Knee osteoarthritis is a phenotype of joint aging best preserved with weight reduction, exercise, and education as core healthspan interventions, while pharmacologic and injectable therapies mainly modulate symptoms and genicular artery embolization remains incompletely validated against sham.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1007/s11357-026-02467-6

build build 880 · 2bcef25 · 2026-11-18